Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.
about
Role of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyClinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancerAfter low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancerLate urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy.Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer.Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.Moderate hypofractionation for prostate cancer: A user's guide.Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer.Reconstructive option after radical mutilating surgery in children with genitourinary rhabdomyosarcoma: When sparing the bladder is not an option.Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice.
P2860
Q26765872-9E344B6D-A584-4264-B050-9BDE1778D21BQ33659901-1C5917E8-9576-4125-8DFE-EAB32C5848C4Q36007746-1FB356B5-1D7C-40D5-AEE1-2527FDE67123Q39007067-6EAD40DD-44CF-4D9F-AAE2-15843BDA7C79Q39995500-CB946895-F508-4ECD-8245-60C8DDF739ADQ40131808-1291DEFF-EE45-4D2E-B857-26FEF285D9B7Q40827296-E5610C26-2B9D-4B57-B5ED-DB0286DA63D5Q41821780-F6462AAD-EB4D-4864-9E82-CA81C8021058Q43150854-264FFE65-F3B1-4854-A83F-C08AD501BE59Q46439191-47900682-D9D0-40EC-9705-25FEF44A514AQ46969507-5A575494-E633-4B5F-8566-AE7D2E11F34CQ48238146-A34C77B0-6C87-42E3-9F35-5E67D10928FAQ49037031-85FFCB70-8E43-4894-B779-D0E04DCD4950Q50420959-BB4A55C5-DA0E-4C47-B5FE-BEAAC754AD5CQ53545027-2680B2BA-8010-4CB9-9788-AA1AA8A7D864Q53766555-9745D1E5-F8D9-485A-9831-01B2440B0977Q54358254-99EC2B67-B9B8-4FD5-93DA-DB5CA630C67DQ54377516-78BE520C-66A7-4083-935A-445A6E50C733Q55152678-40C09AD9-1D5B-40AD-A65C-DBD140A16143
P2860
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of dose to the bladder ...... for localized prostate cancer.
@en
Impact of dose to the bladder ...... for localized prostate cancer.
@nl
type
label
Impact of dose to the bladder ...... for localized prostate cancer.
@en
Impact of dose to the bladder ...... for localized prostate cancer.
@nl
prefLabel
Impact of dose to the bladder ...... for localized prostate cancer.
@en
Impact of dose to the bladder ...... for localized prostate cancer.
@nl
P2093
P2860
P50
P1476
Impact of dose to the bladder ...... for localized prostate cancer
@en
P2093
Andrew Jackson
Ellen Yorke
Jung Hun Oh
Laura Happersett
Marisa Kollmeier
Pirus Ghadjar
P2860
P304
P356
10.1016/J.IJROBP.2013.10.042
P407
P577
2014-02-01T00:00:00Z